The CDC reports that 19 drug-resistant pathogens lead to 9.7 million infections and over 50,000 deaths yearly in the U.S. This issue is considered an urgent public health threat, as resistance continues to exceed new treatment development. The CDC's latest comprehensive assessment in seven years details these threats, ranking them by severity, transmissibility, and available treatment options.Four pathogens are deemed most urgent: Candida auris, drug-resistant gonorrhea, Acinetobacter, and Enterobacterales. Gonorrhea has developed resistance to all but one antibiotic class, while Acinetobacter and Enterobacterales are resistant to "last resort" antibiotics. A new "concerning" threat, Neisseria meningitidis, causes meningococcal disease and is showing growing resistance to penicillin and ciprofloxacin. While childhood vaccinations prevent this illness, its developing resistance warrants monitoring.On a positive note, Clostridioides difficile (C. diff) infections are decreasing annually, leading to its downgrade from an urgent to a serious threat. This update provides a nuanced picture of the ongoing battle against antibiotic resistance.